Interestingly, EGFR-STAT3 activation in myeloid cells protects mice from colitis induction by dextran sodium sulfate treatment (DDS), via regulation of IL-6 production, which prevents intestinal damage leading to IEC proliferation [67]. The gene discussed is IL6; the disease is colitis.